2009•European Journal of Internal MedicineRequires access

P0577 EFFECT OF THE ROSIGLITAZONE/METFORMIN COMBINATION AND THE MONOTHERAPY WITH METFORMIN ON THE COMPONENTS OF THE METABOLIC SYNDROME

António Manuel Pereira De Figueiredo, Mariela Paoli, Gabriela Arata-Bellabarba, Lenín Valeri

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Medicine, Metformin, Rosiglitazone, Metabolic syndrome, Internal medicine, Diabetes mellitus, Pharmacology, Endocrinology

Back to paper search Browse research topics Original source

P0577 EFFECT OF THE ROSIGLITAZONE/METFORMIN COMBINATION AND THE MONOTHERAPY WITH METFORMIN ON THE COMPONENTS OF THE METABOLIC SYNDROME — Research Paper | ScholarLens